Bank of New York Mellon’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.4M Buy
1,625,379
+15,081
+0.9% +$345K 0.01% 1314
2026
Q1
$35.5M Sell
1,610,298
-53,992
-3% -$940K 0.01% 1210
2025
Q4
$19.6M Buy
1,664,290
+570,543
+52% +$7.33M ﹤0.01% 1556
2025
Q3
$17.3M Buy
1,093,747
+39,127
+4% +$568K ﹤0.01% 1621
2025
Q2
$12.1M Buy
1,054,620
+85,529
+9% +$964K ﹤0.01% 1795
2025
Q1
$13.1M Sell
969,091
-80,894
-8% -$1.34M ﹤0.01% 1725
2024
Q4
$17.7M Sell
1,049,985
-438,931
-29% -$8.54M ﹤0.01% 1639
2024
Q3
$30.3M Sell
1,488,916
-117,537
-7% -$2.4M 0.01% 1334
2024
Q2
$36.3M Buy
1,606,453
+22,209
+1% +$582K 0.01% 1218
2024
Q1
$41.6M Sell
1,584,244
-4,202,981
-73% -$120M 0.01% 1145
2023
Q4
$183M Sell
5,787,225
-408,838
-7% -$11.1M 0.04% 398
2023
Q3
$174M Buy
6,196,063
+612,071
+11% +$21M 0.04% 397
2023
Q2
$206M Buy
5,583,992
+3,608,478
+183% +$110M 0.04% 362
2023
Q1
$59.1M Sell
1,975,514
-140,118
-7% -$4.62M 0.01% 899
2022
Q4
$64.8M Sell
2,115,632
-101,349
-5% -$3.04M 0.01% 831
2022
Q3
$54.6M Sell
2,216,981
-36,996
-2% -$1.22M 0.01% 907
2022
Q2
$72.2M Buy
2,253,977
+74,976
+3% +$2.76M 0.02% 761
2022
Q1
$68.6M Sell
2,179,001
-46,227
-2% -$1.45M 0.01% 880
2021
Q4
$74.7M Buy
2,225,228
+39,606
+2% +$1.23M 0.01% 877
2021
Q3
$63.5M Sell
2,185,622
-29,950
-1% -$970K 0.01% 980
2021
Q2
$77.1M Buy
2,215,572
+35,804
+2% +$1.19M 0.01% 856
2021
Q1
$60.8M Sell
2,179,768
-71,154
-3% -$1.89M 0.01% 980
2020
Q4
$55.8M Sell
2,250,922
-847,641
-27% -$20.2M 0.01% 976
2020
Q3
$64.8M Sell
3,098,563
-26,471
-0.8% -$511K 0.02% 764
2020
Q2
$48M Buy
3,125,034
+95,563
+3% +$1.21M 0.01% 903
2020
Q1
$26.9M Sell
3,029,471
-165,327
-5% -$2.38M 0.01% 1106
2019
Q4
$57.8M Buy
3,194,798
+500,177
+19% +$8.31M 0.01% 889
2019
Q3
$40.3M Sell
2,694,621
-84,261
-3% -$1.37M 0.01% 1078
2019
Q2
$66.7M Sell
2,778,882
-105,662
-4% -$3.11M 0.02% 796
2019
Q1
$107M Sell
2,884,544
-261,602
-8% -$9.52M 0.03% 551
2018
Q4
$88.8M Buy
3,146,146
+860,666
+38% +$27.2M 0.03% 569
2018
Q3
$90.1M Buy
2,285,480
+136,801
+6% +$5.99M 0.02% 667
2018
Q2
$95.3M Sell
2,148,679
-285,591
-12% -$14.2M 0.03% 614
2018
Q1
$119M Sell
2,434,270
-132,148
-5% -$6.61M 0.03% 507
2017
Q4
$128M Buy
2,566,418
+194,509
+8% +$10.2M 0.03% 507
2017
Q3
$120M Buy
2,371,909
+173,523
+8% +$8.19M 0.03% 519
2017
Q2
$83.4M Sell
2,198,386
-85,497
-4% -$3.37M 0.02% 670
2017
Q1
$87.9M Sell
2,283,883
-154,187
-6% -$4.64M 0.02% 640
2016
Q4
$53.9M Sell
2,438,070
-267,731
-10% -$5.5M 0.02% 897
2016
Q3
$43.3M Buy
2,705,801
+163,893
+6% +$1.87M 0.01% 965
2016
Q2
$20.9M Sell
2,541,908
-30,683
-1% -$273K 0.01% 1383
2016
Q1
$18M Buy
2,572,591
+226,254
+10% +$1.14M 0.01% 1478
2015
Q4
$12.6M Sell
2,346,337
-85,097
-3% -$544K ﹤0.01% 1712
2015
Q3
$15.7M Buy
+2,431,434
New +$25.5M ﹤0.01% 1585

Other funds holding CC

Bank of New York Mellon's CC Position: Q2 2026 in Review

Bank of New York Mellon increased its Chemours (CC) stake by 0.94% in Q2 2026, buying an estimated $345K and bringing the position to 1,625,379 shares worth $33.4M. The position accounts for 0.01% of the portfolio, ranked #1314.

Bank of New York Mellon first reported a position in CC in Q3 2015 and has held it in 44 quarters since. The position peaked at $206M in Q2 2023. 253 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Bank of New York Mellon held 1,625,379 shares of Chemours worth $33.4M as of Q2 2026.
  • Bank of New York Mellon bought 15,081 Chemours shares in Q2 2026, an estimated $345K.
  • Chemours made up 0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1314 holding.
  • Bank of New York Mellon first reported a position in Chemours in Q3 2015 and has held it in 44 quarters since.
  • Bank of New York Mellon's Chemours position peaked at $206M in Q2 2023.
  • 253 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.